Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amibegron in Major Depressive Disorder
NCT00855530Phase 3Completed
- Sponsor
- Sanofi
- Start
- Sep 2005
- Primary completion
- Jul 2007
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of amibegron in major depressive disorder (MDD), sponsored by Sanofi. Started Sep 2005; status: completed.
02
Drugs
amibegron
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00855530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00855530.